AORT היקף נכסי החברה Artivion Inc
Total assets by ROA demonstrate the fundamental trajectory of Artivion, Inc. (AORT), with the latest reading standing at 957.58. R&D expenses and potential product quality claims are constraining growth. However, success is based on regulatory approvals and demand for stents, while the high complexity of tissue cryopreservation creates a powerful defensive barrier against new entrants in the cardiac surgery niche.
פילוחי מדדים פיננסיים ומדדי שוק עבור Artivion Inc (AORT)
Total assets reflect the aggregate value of all resources held by Artivion, Inc. necessary for business operations. The current level of total assets for the company stands at 957.58, calculated inversely via ROA and the sum of liabilities and equity. The dynamics of this metric are sensitive to logistical disruptions in biomaterial supplies and export restrictions, which directly impact the operating value of the implant manufacturer's global infrastructure.